MIRAMAR, FL, January 08, 2021/ — Generex Biotechnology Corporation (www.generex.com) (OTCQB:GNBT) today announced that it will hold an investor conference call on Friday February 5, 2021 at 9:00 AM.
- Generex Provides Clarification on Its Ii-Key COVID-19 Complete Vaccine China Partnership Agreement
- Generex Biotechnology Announces Call-in Details and Agenda for Shareholder Conference Call on Thursday May 6, 2021 at 9:00 AM
- Generex Biotechnology Subsidiary Olaregen Therapeutix Announces Agreement with Nexgen Medical for Distribution of Excellagen® Wound Conforming Matrix in Malaysia
- Generex Provides Update on its Ii-Key COVID-19 Complete Vaccine Program: Advancing Global Development
- NuGenerex Immuno-Oncology Submits Protocol, Data, and Manufacturing Information to FDA in Advance of the IND Submission